Biotika AS (XBRA:1BSL01AE) Receivables Turnover : 17.39 (As of Jun. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Biotika AS Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Biotika AS's Revenue for the six months ended in Jun. 2023 was €9.28 Mil. Biotika AS's average Accounts Receivable for the six months ended in Jun. 2023 was €0.53 Mil. Hence, Biotika AS's Receivables Turnover for the six months ended in Jun. 2023 was 17.39.

Biotika AS Receivables Turnover Historical Data

The historical data trend for Biotika AS's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotika AS Receivables Turnover Chart

Biotika AS Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Receivables Turnover

Get a 7-Day Free Trial

10.10

9.44

14.06

11.84

19.54

Biotika AS Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Receivables Turnover	Get a 7-Day Free Trial															8.68	8.49	16.27	-	17.39

Competitive Comparison of Biotika AS's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Biotika AS's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotika AS's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biotika AS's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Biotika AS's Receivables Turnover falls into.

Biotika AS Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Biotika AS's Receivables Turnover for the fiscal year that ended in Dec. 2022 is calculated as

	Receivables Turnover (A: Dec. 2022 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2022 )	/ (	(Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )
=	11.03	/ (	(0.682	+	0.447)	/	2 )
=	11.03	/	0.5645
=	19.54

Biotika AS's Receivables Turnover for the quarter that ended in Jun. 2023 is calculated as

	Receivables Turnover (Q: Jun. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Jun. 2023 )	/ (	(Accounts Receivable (Q: Dec. 2022 )	+	Accounts Receivable (Q: Jun. 2023 ))	/	count )
=	9.275	/ (	(0.447	+	0.62)	/	2 )
=	9.275	/	0.5335
=	17.39

Biotika AS (XBRA:1BSL01AE) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Biotika AS Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Biotika AS's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotika AS (XBRA:1BSL01AE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biotika AS (XBRA:1BSL01AE) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

Slovenskc Lupca 566, Banská Bystrica, SVK, 976 13

Website

https://www.biotika.sk

Biotika AS is a manufacturer of pharmaceutical preparations for the human and veterinary application. It is engaged in the production of Active Pharmaceutical Ingredients (API), contract manufacturing of API, and contract manufacturing of final dosage formulations. It also offers research and development services. It manufacturers Polymyxine B Sulfate and other API for third parties (toll manufacturing) of pharmaceutical quality. Biotika is well known as a reliable manufacturer of high-quality pharmaceutical preparations for the human as well as veterinary application and also as a very important producer of the feed additives for breeding farm animals.

Biotika AS (XBRA:1BSL01AE) Headlines

No Headlines